Primary Site >> Stomach Cancer

Gene >> CNDP2

  • 2003
  • 2010
  • 2011
  • 2013
  • 2014
  • 2017
  • 2018
Ref: Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation.
PMID: 14711984
Ref: [Long-term disease-free survival following multimodal treatment in a patient with curatively unresectable advanced gastric cancer with metachronous liver metastasis].
PMID: 21224593
Ref: [A case of stage III B advanced gastric cancer with psoriasis vulgaris responding to S-1/CDDP neoadjuvant chemotherapy leading to a pathologically complete response].
PMID: 21566446
Ref: [A case of advanced gastric cancer with tumor embolus in the portal vein successfully treated with S-1 and CDDP therapy].
PMID: 21772106
Ref: [Type 4 advanced gastric cancer responding to histological complete response after neoadjuvant S-1 combined with CDDP therapy-report of a case].
PMID: 21829073
Ref: [A case of advanced gastric cancer effectively treated with weekly paclitaxel as neoadjuvant chemotherapy].
PMID: 24196077
Ref: Underexpressed CNDP2 participates in gastric cancer growth inhibition through activating the MAPK signaling pathway.
PMID: 24395568
Ref: [Long-Term Survival of a Gastric Neuroendocrine Carcinoma Patient with Extra-Regional Lymph Node Metastases].
PMID: 28428516
Ref: [A Successful Treatment for Stage III c Gastric Cancer with Low Cardiac Function Using S-1 plus Oxaliplatin(SOX)as a Neoadjuvant Chemotherapy].
PMID: 29394811
Ref: Validation of the prognostic impact of the new tumor-node-metastasis clinical staging in patients with gastric cancer.
PMID: 29357013
Ref: [A Case of Double Lung and Gastric Cancer Involving Para-Aortic Lymph Node Metastasis with Difficult Preoperative Diagnosis].
PMID: 29362340
Ref: Prognostic factors for cytology-positive gastric cancer.
PMID: 30167924